Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Neurogene Inc increased its cash reserves by 81.32%, or 66.70m. Cash Flow from Financing totalled 92.48m or -- of revenues. In addition the company used 51.42m for operations while cash from investing totalled 25.64m.
Cash flow per share | -4.12 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 11.93 |
---|---|
Tangible book value per share | 11.93 |
More ▼
Balance sheet in USDView more
Current ratio | 12.17 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0007 |
---|---|
Total debt/total capital | 0.0007 |
More ▼